LAUSR

Prolonged severe neutropenia after the first daratumumab administration for multiple myeloma with baseline neutropenia

Sign Up to like & get
recommendations!
0 Published in 2019 at "Annals of Hematology"

DOI: 10.1007/s00277-019-03711-0

Abstract: Dear Editor, Daratumumab, an anti-CD38 monoclonal antibody, shows substantial efficacy for relapsed and refractory multiple myeloma (MM). Daratumumab also has a clinically manageable and acceptable safety profile. Grade 3–4 neutropenia was recorded in 5–12% of… read more here.

Keywords: treatment; severe neutropenia; therapy; neutropenia ... See more keywords

Hypothermia as a forgotten sign of prolonged severe hypoglycaemia

Sign Up to like & get
recommendations!
0 Published in 2018 at "BMJ Case Reports"

DOI: 10.1136/bcr-2018-225606

Abstract: Hypothermia is often a sign of serious illness. Commonly reported aetiologies include but are not limited to sepsis, exposure to cold and endocrine disorders. Hypoglycaemia, a common occurrence, is rarely associated with hypothermia. We present… read more here.

Keywords: hypothermia; sign prolonged; hypothermia forgotten; hypoglycaemia ... See more keywords

Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel

Sign Up to like & get
recommendations!
0 Published in 2025 at "Blood Advances"

DOI: 10.1182/bloodadvances.2025016824

Abstract: Key Points • PSN occurred in 15% and 21% of CAR-T recipients in training and validation cohorts, respectively, and was associated with inferior survival.• The CytoRisk score predicted PSN with high specificity (93%), sensitivity (74%),… read more here.

Keywords: prediction prolonged; characterization prediction; pediatric patients; neutropenia pediatric ... See more keywords